Table 7.
Variable | Change |
Supplemented Group
(n = 16) |
Control Group
(n = 19) |
||
---|---|---|---|---|---|
Δ I–II | Δ I–III | Δ I–II | Δ I–III | ||
FSTL-1 | Δ I–II | 0.02 | 0.03 | 0.18 | 0.09 |
Δ I–III | 0.31 | 0.24 | 0.19 | 0.12 | |
IL-6 | Δ I–II | −0.37 * | −0.34 | −0.33 | −0.26 |
Δ I–III | 0.03 | −0.01 | −0.12 | −0.12 | |
IL-10 | Δ I–II | −0.26 | −0.19 | −0.14 | −0.11 |
Δ I–III | 0.14 | 0.13 | 0.06 | −0.08 | |
IL-15 | Δ I–II | −0.27 | −0.33 | −0.40 | −0.50 * |
Δ I–III | −0.41 * | −0.45 * | −0.13 | −0.28 | |
Leptin | Δ I–II | 0.10 | 0.20 | 0.50 * | 0.58 * |
Δ I–III | −0.11 | −0.15 | −0.27 | −0.31 | |
LIF | Δ I–II | 0.14 | 0.20 | 0.37 | 0.47 |
Δ I–III | −0.19 | −0.18 | −0.06 | −0.13 | |
Resistin | Δ I–II | −0.12 | −0.08 | 0.14 | 0.08 |
Δ I–III | 0.17 | 0.21 | 0.26 | 0.33 | |
OSM | Δ I–II | 0.03 | −0.14 | −0.22 | −0.43 |
Δ I–III | 0.07 | 0.03 | 0.40 | 0.29 | |
TIMP-1 |
Δ I–II
Δ I–III |
0.18
−0.23 |
0.12
−0.22 |
−0.07
−0.01 |
−0.09
−0.10 |
Note: Markers: FSTL-1, follistatin-like 1; IL, interleukin; LIF, leukemia inhibitory factor; OSM, oncostatin M; TIMP-1, tissue inhibitor of metalloproteinase 1. Study design: Δ I–II, difference between the values before and immediately after the ultramarathon; Δ I–III, difference between the values before and 24 h after the ultramarathon. Significant difference detected at * p ≤ 0.05.